As societal attitudes have become more accepting of marijuana and many states have legalized it in some form, the cannabis industry is seen by many as an increasingly attractive business opportunity. In particular, cannabidiol (CBD), a cannabis derivative, has become progressively more popular for its perceived health benefits, including pain and stress relief, acne treatment, and even a treatment for cancer and seizures. CBD can be found in an array of products from edibles to face creams, vaping pens, and topical oils.
Recent developments in federal law have removed major obstacles to the CBD industry, and all expectations are that the industry is set to experience exponential growth. Indeed, some estimate that it will be a $22 billion industry by 2020. Brightfield Group, Profitable Insights into the CBD and Cannabis Industry (2018).
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
